Journal article
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism
Abstract
Dabigatran was as effective as warfarin for the acute treatment of venous thromboembolism in the RE-COVER and RE-COVER II trials. We compared the incidence of bleeding with dabigatran versus warfarin in pooled data from these studies. The localisation, bleeding severity, and the impact of key factors on the incidence of bleeding, were compared between the dabigatran and warfarin treatment group. Altogether, 2553 patients received dabigatran and …
Authors
Majeed A; Goldhaber SZ; Kakkar A; Kearon C; Eriksson H; Kreuzer J; Feuring M; Hantel S; Friedman J; Schellong S
Journal
Thrombosis and Haemostasis, Vol. 115, No. 02, pp. 291–298
Publisher
Thieme
Publication Date
March 2016
DOI
10.1160/th15-04-0319
ISSN
0340-6245